This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergicreaction. Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergicreaction. Read More EMCrit: Podcast 145 – Awake Intubation Lecture from SMACC ERCast: Angioedema References: Baş M et al.
Background: Diphenhydramine, a first-generation antihistamine, is the most common pharmacologic agent used to treat acute allergicreactions. Article: Abella BS et al. 7 (5.5%) patients in the IV cetirizine group returned to any ED or clinic within 48 hours compared to 19 (14.1%) in the IV diphenhydramine group; P=0.02
This is called a biphasic reaction. The risk of a biphasic reaction is what keeps patients in the ED while being observed for a set period of time. The overall incidence of biphasic reactions is unknown with rates quoted from < 0.5% The American Journal of Emergency Medicine 2018 Aug;36(8):1480-1485 Shaker M, et al.
A 27-year-old male presents to the ED for left eye pain after being hit in the face with a spare car part while working under the hood of his car. What is the diagnosis, and how do we manage it from the ED? Lu, Kevin, et al. We’ll keep it short, while you keep that EM brain sharp. 95% occupational injuries occur in males [1].
He has been taking increased doses of torsemide without improvement in his symptoms and was directed to the ED for inpatient therapy. Now, a remote outpatient pulmonary arterial pressure monitor and other heart failure detection devices (Table 1) are available that you may begin to see in your ED. 8 The device itself is 2 x 2.5
These steroids are undoubtedly part of the cocktail we reach for in patients presenting with acute asthma, allergicreactions, or anaphylaxis - and traditional clinical logic has taught us these drugs work to reduce inflammation in the airways and reduce bronchial mucus production. Basic & clinical pharmacology (12th ed.).
The use of CTA (computed tomography angiography) in the emergency department (ED) has increased dramatically in the past 20 years. of all patients in the ED for over 800 different stated indications. The use of CTA (computed tomography angiography) in the emergency department (ED) has increased dramatically in the past 20 years.
Reference: Bannelier et al. Case: A 57-year-old woman presents to the emergency department (ED) with pleuritic posterior chest/back pain, shortness of breath, and left leg swelling. Background: Pulmonary embolism (PE) is a potentially life-threatening diagnosis that ED physicians must always have on their radar.
A previously healthy 23-year-old male with no medical or surgical history presents to the ED with generalized malaise and no energy, progressively getting worse over the last six weeks. In: Newburger P, Rosmarin AG, eds. link] Laxminarayana SLK, Jayaram S, Swaminathan SM et al. 10^9/L) Moderate (0.50.9 Medications: 25.6%
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content